117 related articles for article (PubMed ID: 10605492)
1. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
[TBL] [Abstract][Full Text] [Related]
2. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
Zinyowera S; Muchaneta-Kubara CE; Mutapi F; Midzi N; Ndlovu PD; Mduluza T
Cent Afr J Med; 2006; 52(9-12):104-11. PubMed ID: 20353134
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.
Mutapi F; Ndhlovu PD; Hagan P; Spicer JT; Mduluza T; Turner CM; Chandiwana SK; Woolhouse ME
J Infect Dis; 1998 Jul; 178(1):289-93. PubMed ID: 9652458
[TBL] [Abstract][Full Text] [Related]
4. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults.
Grogan JL; Kremsner PG; van Dam GJ; Metzger W; Mordmüller B; Deelder AM; Yazdanbakhsh M
J Infect Dis; 1996 May; 173(5):1242-7. PubMed ID: 8627078
[TBL] [Abstract][Full Text] [Related]
5. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children.
Naus CW; van Dam GJ; Kremsner PG; Krijger FW; Deelder AM
Clin Infect Dis; 1998 May; 26(5):1142-7. PubMed ID: 9597243
[TBL] [Abstract][Full Text] [Related]
6. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
[TBL] [Abstract][Full Text] [Related]
7. Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.
Wilson S; Jones FM; Fofana HK; Doucouré A; Landouré A; Kimani G; Mwatha JK; Sacko M; Vennervald BJ; Dunne DW
PLoS Negl Trop Dis; 2013; 7(3):e2149. PubMed ID: 23556029
[TBL] [Abstract][Full Text] [Related]
8. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection.
Mduluza T; Ndhlovu PD; Madziwa TM; Midzi N; Zinyama R; Turner CM; Chandiwana SK; Nyazema N; Hagan P
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():157-64. PubMed ID: 11586443
[TBL] [Abstract][Full Text] [Related]
9. Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.
Mduluza T; Ndhlovu PD; Midzi N; Scott JT; Mutapi F; Mary C; Couissinier-Paris P; Turner CM; Chandiwana SK; Woolhouse ME; Dessein AJ; Hagan P
Immunol Lett; 2003 Sep; 88(3):249-56. PubMed ID: 12941484
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso.
Koukounari A; Gabrielli AF; Toure S; Bosque-Oliva E; Zhang Y; Sellin B; Donnelly CA; Fenwick A; Webster JP
J Infect Dis; 2007 Sep; 196(5):659-69. PubMed ID: 17674306
[TBL] [Abstract][Full Text] [Related]
11. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
Asuming-Brempong EK; Ayi I; van der Puije W; Gyan BA; Larbi IA; Ashong Y; Frempong NA; Quartey JK; Otchere J; Jones FM; Wilson S; Dunne DW; Boakye DA
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
[TBL] [Abstract][Full Text] [Related]
12. Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy.
Van Etten L; Kremsner PG; Krijger FW; Deelder AM
Am J Trop Med Hyg; 1997 Sep; 57(3):337-41. PubMed ID: 9311646
[TBL] [Abstract][Full Text] [Related]
13. The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-aged children in Mali.
Sacko M; Magnussen P; Traoré M; Landouré A; Doucouré A; Reimert CM; Vennervald BJ
Parasitology; 2009 Nov; 136(13):1851-7. PubMed ID: 19281636
[TBL] [Abstract][Full Text] [Related]
14. Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment.
Bourke CD; Nausch N; Rujeni N; Appleby LJ; Trottein F; Midzi N; Mduluza T; Mutapi F
PLoS Negl Trop Dis; 2014 May; 8(5):e2846. PubMed ID: 24810615
[TBL] [Abstract][Full Text] [Related]
15. Observations on possible immunity to reinfection among school children after schistosomiasis treatment.
Nagaty IM; el Hayawan IA; Nasr ME; el Hamshery AH
J Egypt Soc Parasitol; 1996 Aug; 26(2):443-52. PubMed ID: 8754652
[TBL] [Abstract][Full Text] [Related]
16. The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique.
Augusto G; Magnussen P; Kristensen TK; Appleton CC; Vennervald BJ
Parasitology; 2009 Nov; 136(13):1771-9. PubMed ID: 19490727
[TBL] [Abstract][Full Text] [Related]
17. Urinary soluble egg antigen levels in Schistosoma haematobium infection in relation to sex and age of Kenyan schoolchildren following praziquantel treatment.
Kihara JH; Njagi EN; Kenya EU; Mwanje MT; Odek AE; van Dam G; Kahama AI; Ouma JH
Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1024-30. PubMed ID: 19647844
[TBL] [Abstract][Full Text] [Related]
18. Detection of cellular and humoral markers (IL-2, IFN-gamma and IgE) in sera of patients with urinary schistosomiasis.
Khalil HM; Sadek MS; el-Baki MH; Khalil NM; Karam ; Makled M; Girgis F; Abd el-Aziz SS
J Egypt Soc Parasitol; 1995 Aug; 25(2):513-24. PubMed ID: 7665948
[TBL] [Abstract][Full Text] [Related]
19. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
[TBL] [Abstract][Full Text] [Related]
20. Circulating anodic and cathodic antigen in serum and urine from Schistosoma haematobium-infected Cameroonian children receiving praziquantel: a longitudinal study.
Kremsner PG; Enyong P; Krijger FW; De Jonge N; Zotter GM; Thalhammer F; Mühlschlegel F; Bienzle U; Feldmeier H; Deelder AM
Clin Infect Dis; 1994 Mar; 18(3):408-13. PubMed ID: 8011824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
